Literature DB >> 10455115

Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases.

Q A Sun1, Y Wu, F Zappacosta, K T Jeang, B J Lee, D L Hatfield, V N Gladyshev.   

Abstract

The intracellular generation of reactive oxygen species, together with the thioredoxin and glutathione systems, is thought to participate in redox signaling in mammalian cells. The activity of thioredoxin is dependent on the redox status of thioredoxin reductase (TR), the activity of which in turn is dependent on a selenocysteine residue. Two mammalian TR isozymes (TR2 and TR3), in addition to that previously characterized (TR1), have now been identified in humans and mice. All three TR isozymes contain a selenocysteine residue that is located in the penultimate position at the carboxyl terminus and which is encoded by a UGA codon. The generation of reactive oxygen species in a human carcinoma cell line was shown to result in both the oxidation of the selenocysteine in TR1 and a subsequent increase in the expression of this enzyme. These observations identify the carboxyl-terminal selenocysteine of TR1 as a cellular redox sensor and support an essential role for mammalian TR isozymes in redox-regulated cell signaling.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10455115     DOI: 10.1074/jbc.274.35.24522

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.

Authors:  S R Lee; S Bar-Noy; J Kwon; R L Levine; T C Stadtman; S G Rhee
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  How selenium has altered our understanding of the genetic code.

Authors:  Dolph L Hatfield; Vadim N Gladyshev
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

3.  Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction.

Authors:  Robyn L Poerschke; Philip J Moos
Journal:  Biochem Pharmacol       Date:  2010-10-12       Impact factor: 5.858

4.  Selective targeting of selenocysteine in thioredoxin reductase by the half mustard 2-chloroethyl ethyl sulfide in lung epithelial cells.

Authors:  Yi-Hua Jan; Diane E Heck; Joshua P Gray; Haiyan Zheng; Robert P Casillas; Debra L Laskin; Jeffrey D Laskin
Journal:  Chem Res Toxicol       Date:  2010-06-21       Impact factor: 3.739

5.  Methaneseleninic acid is a substrate for truncated mammalian thioredoxin reductase: implications for the catalytic mechanism and redox signaling.

Authors:  Gregg Snider; Leah Grout; Erik L Ruggles; Robert J Hondal
Journal:  Biochemistry       Date:  2010-11-10       Impact factor: 3.162

Review 6.  Selenoproteins and their impact on human health through diverse physiological pathways.

Authors:  Behzad Moghadaszadeh; Alan H Beggs
Journal:  Physiology (Bethesda)       Date:  2006-10

Review 7.  Thiol chemistry in peroxidase catalysis and redox signaling.

Authors:  Alberto Bindoli; Jon M Fukuto; Henry Jay Forman
Journal:  Antioxid Redox Signal       Date:  2008-09       Impact factor: 8.401

8.  Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival.

Authors:  Sally Järvelä; Järvelä Sally; Helena Bragge; Bragge Helena; Niina Paunu; Paunu Niina; Timo Järvelä; Järvelä Timo; Leo Paljärvi; Paljärvi Leo; Hannu Kalimo; Kalimo Hannu; Pauli Helén; Helén Pauli; Vuokko Kinnula; Kinnula Vuokko; Ylermi Soini; Soini Ylermi; Hannu Haapasalo; Haapasalo Hannu
Journal:  J Neurooncol       Date:  2006-04       Impact factor: 4.130

9.  CUG start codon generates thioredoxin/glutathione reductase isoforms in mouse testes.

Authors:  Maxim V Gerashchenko; Dan Su; Vadim N Gladyshev
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

10.  Selenium and thyroid autoimmunity.

Authors:  Roberto Negro
Journal:  Biologics       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.